Gene delivery using adeno-associated virus (AAV) vectors is a widely used method to transduce neurons in the brain, especially due to its safety, efficacy, and long-lasting expression. In addition, by varying AAV serotype, promotor, and titer, it is possible to affect the cell specificity of expression or the expression levels of the protein of interest. Dopamine neurons in the substantia nigra projecting to the striatum, comprising the nigrostriatal pathway, are involved in movement control and degenerate in Parkinson's disease. AAV-based gene targeting to the projection area of these neurons in the striatum has been studied extensively to induce the production of neurotrophic factors for disease-modifying therapies for Parkinson's disease...
Viral vector-mediated gene transfer utilizing adeno-associated viral vectors has recently entered cl...
Parkinson’s disease is predominantly a dopamine deficiency syndrome, which is produced in the brain ...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Gene delivery using adeno-associated virus (AAV) vectors is a widely used method to transduce neuron...
Gene delivery using adeno-associated virus (AAV) vectors is a widely used method to transduce neuron...
Recombinant adeno-associated viral (AAV) vectors of serotypes 6, 8, and 9 were characterized as tool...
Dysfunction of the nigrostriatal system is the major cause of Parkinson's disease (PD). This brain r...
During the last few years, recombinant viral vectors derived from adenovirus (Ad), adeno-associated ...
Cerebral dopamine neurotrophic factor (CDNF) protein has been shown to protect the nigrostriatal dop...
In order to study the molecular pathways of Parkinson's disease (PD) and to develop novel therapeuti...
Gene transfer to the brain is a promising therapeutic strategy for a variety of neurodegenerative di...
Abstract Background The pathological hallmarks of Par...
In order to study the molecular pathways of Parkinson's disease (PD) and to develop novel therapeuti...
During the last decade, identification of the genes involved in familial forms of Parkinson's diseas...
Viral vector-mediated gene transfer utilizing adeno-associated viral vectors has recently entered cl...
Viral vector-mediated gene transfer utilizing adeno-associated viral vectors has recently entered cl...
Parkinson’s disease is predominantly a dopamine deficiency syndrome, which is produced in the brain ...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Gene delivery using adeno-associated virus (AAV) vectors is a widely used method to transduce neuron...
Gene delivery using adeno-associated virus (AAV) vectors is a widely used method to transduce neuron...
Recombinant adeno-associated viral (AAV) vectors of serotypes 6, 8, and 9 were characterized as tool...
Dysfunction of the nigrostriatal system is the major cause of Parkinson's disease (PD). This brain r...
During the last few years, recombinant viral vectors derived from adenovirus (Ad), adeno-associated ...
Cerebral dopamine neurotrophic factor (CDNF) protein has been shown to protect the nigrostriatal dop...
In order to study the molecular pathways of Parkinson's disease (PD) and to develop novel therapeuti...
Gene transfer to the brain is a promising therapeutic strategy for a variety of neurodegenerative di...
Abstract Background The pathological hallmarks of Par...
In order to study the molecular pathways of Parkinson's disease (PD) and to develop novel therapeuti...
During the last decade, identification of the genes involved in familial forms of Parkinson's diseas...
Viral vector-mediated gene transfer utilizing adeno-associated viral vectors has recently entered cl...
Viral vector-mediated gene transfer utilizing adeno-associated viral vectors has recently entered cl...
Parkinson’s disease is predominantly a dopamine deficiency syndrome, which is produced in the brain ...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...